Acadia Pharmaceuticals ACAD Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's asset turnover?
- Acadia Pharmaceuticals (ACAD) reported asset turnover of 0.8× in Q1 2026.
- How has Acadia Pharmaceuticals's asset turnover changed year-over-year?
- Acadia Pharmaceuticals's asset turnover decreased by 20.2% year-over-year, from 1× to 0.8×.
- What is the long-term trend for Acadia Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's asset turnover has grown at a 6.7% compound annual growth rate (CAGR), from 0.6× to 0.8×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.